Log in or Sign up for Free to view tailored content for your specialty!
Infection News
Statins reduce liver cancer risk in patients with chronic HBV
Statin therapy correlated with a reduced risk for hepatocellular carcinoma in patients with chronic hepatitis B, according to results published in Hepatology.
FDA expands Mavyret approval for adults, children with any HCV genotype
The FDA has expanded the approval of Mavyret for a treatment duration of 8 weeks to include treatment-naive adults and children aged 12 years and older with chronic hepatitis C genotype 1 through 6 and compensated cirrhosis.
Log in or Sign up for Free to view tailored content for your specialty!
Norovirus outbreak in pediatric ward highlights challenges of infection control
Researchers reported findings from a norovirus outbreak in a pediatric ward with multiple-bed rooms and emphasized the importance of early detection and prompt implementation of strict infection control measures.
Q&A: Guideline updates for HCV infection in patients with chronic kidney disease
The introduction and success of direct-acting antivirals drove the Kidney Disease: Improving Global Outcomes work group to make major updates to its clinical practice guidelines regarding hepatitis C virus infection in chronic kidney disease, or CKD.
7 recent FDA updates you may have missed
Healio Gastroenterology and Liver Disease has compiled a list of some of the most recent approvals and updates from the FDA.
Alcoholic hepatitis drug candidate shows ‘life-saving potential’
Data from a phase 2a clinical trial of DUR-928, an endogenous, small-molecule new chemical entity, for patients with alcoholic hepatitis demonstrated that the treatment led to greater reductions from baseline in bilirubin and MELD and improved Lille scores compared with a historical control group from a University of Louisville alcoholic hepatitis study, according to a company press release.
Australia will miss HBV elimination targets despite improved care
Results from an estimation model revealed that Australia will marginally miss both its local targets and the WHO’s global targets for eliminating chronic hepatitis B.
H. pylori treatment, vitamins, garlic reduce gastric cancer mortality
Over the course of 22 years of follow-up, treatment for Helicobacter pylori infection, as well as vitamin and garlic supplementation, reduced the risk for death due to gastric cancer.
Disposable duodenoscopes one ‘menu option’ to reduce infection risk
Late last month, the FDA released a new recommendation that manufacturers and health care facilities start making the transition to duodenoscopes that have disposable components to reduce potential incidents of contamination or infection.
HCV-viremic kidneys provide similar efficacy in recipients as uninfected organs
By 2019, hepatitis C-seronegative patients who underwent kidney transplantation mostly received HCV-viremic donor organs, which demonstrated the same level of function as uninfected kidneys over the course of 1-year follow-up.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read